Inhibikase Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold IKT, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

18
Funds holding
$36322571
Total value held
Buying
11 added/new · 5 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $15769155 7768057 +1464624 +23.24%
2 Blackstone Inc. $12054700 5938276 +5938276 NEW BUY
3 State Street Corp $3875475 1909101 +223285 +13.24%
4 Northern Trust Corp $1783527 878585 +159785 +22.23%
5 Bank Of New York Mellon Corp $615346 303126 +89918 +42.17%
6 Jpmorgan Chase & Co $610988 316574 -11944 -3.64%
7 Ubs Group Ag $415448 204654 +204654 NEW BUY
8 Morgan Stanley $231432 114006 -50253 -30.59%
9 Bank Of America Corp /De/ $219288 108024 -214680 -66.53%
10 Wells Fargo & Company/Mn $206737 101841 +61310 +151.27%
11 Invesco Ltd. $126069 62103 +62103 NEW BUY
12 Citigroup Inc $113863 56090 +52804 +1606.94%
13 Goldman Sachs Group Inc $101845 50170 -99687 -66.52%
14 Sei Investments Co $97363 47962 Held
15 Barclays Plc $40042 19725 -1623 -7.60%
16 Prudential Financial Inc $37129 18290 +3110 +20.49%
17 Royal Bank Of Canada $24000 12199 +10585 +655.82%
18 Pnc Financial Services Group, Inc. $164 81 Held

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.